Mexiletine has a local anesthetic effect on sciatic nerve blockade in rats

Drug Development Research

Volumn 67, Issue 12, 2006, Pages 905-909

  Cheng, Kuang I ^a,b   Shieh, Ja Ping ^b   Lin, Ching Nan ^b   Chu, Koung Shing ^a   Kwan, Aij Lie ^a   Hou, Chia Hui ^b   Wang, Jhi Joung ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Antiarrhythmic; Local anaesthetic; Mexiletine; Sodium channel

Indexed keywords

ANTIARRHYTHMIC AGENT; BUPIVACAINE; LIDOCAINE; MEXILETINE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; EVALUATION; LOCAL ANESTHESIA; MALE; MOTOR PERFORMANCE; NERVE BLOCK; NOCICEPTION; NONHUMAN; RAT; SCIATIC NERVE;

EID: 34247252061     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20162     Document Type: Article

References (17)

1. Campbell TJ, Williams KM. 2001. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Pharmacol 52:21S-34S.
2. Chen YW, Huang KL, Liu SY, Tzeng JI, Chu KS, Lin MT, Wang JJ. 2004. Intrathecal tri-cyclic antidepressants produce spinal anesthesia. Pain 12:106-112.
3. Fozzard HA, Lee PJ, Lipkind GM. 2005. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des 11:2671-2886.
4. Gerner P, Mujtaba M, Khan M, Sudoh Y, Vlassakov K, Anthony DC, Wang GK. 2002. N-phenylethyl amitriptyline in rat sciatic nerve blockade. Anesthesiology 96:1435-1442.
5. Hewitt KE, Stys PK, Lesiuk HJ. 2001. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury. Brain Res 898:281-287.
6. Jarvis B, Coukell AJ. 1998. Mexiletine. A review of its therapeutic use in painful diabetic neuropathy. Drugs 56:691-707.
7. Kowey PR. 1998. Pharmacological effects of antiarrhythmic drugs. Arch Intern Med 158:325-332.
8. Kowey PR, Marinchak RA, Rials SJ, Bharucha DB. 2000. Classification and pharmacology of antiarrhythmic drugs. Am Heart J 140:12-20.
9. Labbé L, Turgeon J. 1999. Clinical pharmacokinetics of mexiletine. Clin Pharmacokinet 37:361-384.
10. 50. Biometrics 55:1030-1037.
11. McLure HA, Rubin AP. 2005. Review of local anaesthetic agents. Minerva Anestesiol 71:59-74.
12. Ritschel WA, Kearns GL. 2004. Area under the blood level-time curve. In: Handbook of basic pharmacokinetics...including clinical applications. 6th ed. Washington, DC: Am Pharm Assoc. p 179-187.
13. Scholz, A. 2002. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 89:52-61.
14. Sloan P, Basta M, Storey P, von Gunten C. 1999. Mexiletine as an adjuvant analgesic for the management of neuropathic cancer pain. Anesth Analg 89:760-761.
15. Stys PK, Lesiuk H. 1996. Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter. Neuroscience 71:27-36.
16. Sudoh Y, Cahoon EE, Gerner P, Wang GK. 2003. Tricyclic antidepressants as long-acting local anesthetics. Pain 103:49-55.
17. Tallarida RJ. 2001. Drug synergism: its detection and applications. J Pharmacol Exp Ther 298:865-872.